(818) 431-5208

info@mahealthcareadvisors.com

REFERRAL PROGRAM

BUYER REGISTRATION
  • WHO WE ARE
  • SERVICES
    • Sell Your Company
    • M&A Consultation
    • Expert Valuations
    • Broker-Dealer
  • TRANSACTIONS
  • INSIGHTS
    • The Selling Process
    • The M&A Market
    • M&A Insights Podcast
  • PRESS
  • CONTACT US

Press

We Manage the Sale Process, So You Can Manage Your Business


The Selling Process, Video

Video: Seller Representation – Step 2

March 29, 2022
Read More
The Selling Process, Video

Video: Seller Representation – Step 1

March 29, 2022
Read More
The M&A Market, Video

Video: 2022 M&A Transactional Outlook Part 1

Mike Moran of M&A Healthcare Advisors provides part 1 of the firm’s 2022 M&A transactional outlook.

March 29, 2022
Read More
The M&A Market, Video

Video: 2022 M&A Transactional Outlook Part 2

Andre Ulloa provides the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy. M&A Healthcare Advisors has

March 29, 2022
Read More
Press

Watchdog sounds alarm over private equity investment in home health, hospice

M&A advisor Michael Moran believes the watchdog group’s concerns are overblown. His firm M&A Healthcare Advisors helps home health and

March 23, 2022
Read More
Press

Inflation adds element of uncertainty to home care, hospice deals

“Investors continue to see healthcare services companies as great places to put their money,” Andre Ulloa, partner with M&A Healthcare

March 18, 2022
Read More
Uncategorized

Video: Big M&A Questions: Part 1

Why Do I Need An Advisor? The bottom line is that selling a company is very challenging. If you haven’t

March 16, 2022
Read More
Video

Video: MarketScale – 2022 M&A Healthcare Advisors Transactional Outlook Part Two: Pharmacy

Andre Ulloa, Partner and Executive Advisor at M&A Healthcare Advisors, shares part 2 of our 2022 transactional outlook covering four

March 11, 2022
Read More
Press

Andre Ulloa of M&A Healthcare Advisors Discussed Aveanna Reported Interest In Enhabit

Andre Ulloa, partner with M&A Healthcare Advisors, told McKnight’s Home Care Daily Pulse in an email that Enhabit could be

March 8, 2022
Read More
The M&A Market

Video: MarketScale – M&A Healthcare Advisors Announces 2022 Transactional Outlook, Market Update

"Being able to do important work, do it well, and receive the confidence from clients that we’ve represented in selling

January 19, 2022
Read More
Load More
(818) 431-5208 | info@mahealthcareadvisors.com | M&A Healthcare Advisors, 4500 Park Granada Blvd, Suite 202, Calabasas, CA 91302
About Transactions Insights Press Contact Us Privacy Policy
Securities are offered through Finalis Securities LLC , Member FINRA / SIPC . M&A Healthcare Advisors is not a registered broker-dealer, and M&A Healthcare Advisors and Finalis Securities LLC are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.
www.mahealthcareadvisors.com (the “M&A Healthcare Advisors Website”) is a website operated by M&A Healthcare Advisors. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy and is subject to change without notice.
Finalis Privacy Policy | Business Continuity Plan | FINRA BrokerCheck | SIPC | Finalis Form CRS
Copyright © 2026 M&A Healthcare Advisors. All rights reserved.

Market Research

The first step in any valuation is to explore what drives value within your specific market segment. In the healthcare sector, understanding industry trends and identifying key market drivers is essential to understanding what makes your business unique.

  • Industry Trends: The healthcare landscape is constantly evolving. Factors such as regulatory changes, technological advancements, reimbursement risk, skilled caregiver supply, and shifts in patient demographics can significantly impact your business’s value. Staying ahead of these trends and adapting your operations accordingly can make your company more attractive to potential buyers in the market.
  • Key Market Drivers: Patient outcomes, cost-efficiency, and specialized services are often critical value drivers in the eyes of a potential acquirer. For example, a company with a track record of delivering better patient outcomes or offering services that are currently in high demand can be factors which elevate your perceived valuation.
  • Identifying Competition and Market Position: Benchmarking your business against competitors or other operator profiles can provide a clearer picture of your market position. This involves analyzing competitor strengths, weaknesses, and growth strategies to highlight your company’s competitive advantage.

Transaction Comparatives

Once we have a solid understanding of your market, we move on to examining recent transactions in the healthcare sector to identify valuation benchmarks.

  • Assessing Comparable Transactions: By analyzing similar deals, we identify comparable businesses that have recently gone through an M&A transaction. This helps us understand the market’s value expectations for companies that operate with a similar profile to your business. While every business is unique, one of the most effective ways to estimate the value of your business is through benchmarking your company with similar companies who have sold in the open market.  With our extensive experience in healthcare M&A, we have transactional comparative data t relative to your business.
  • Market Multiples: One of the key metrics utilized in M&A is the Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) multiple. EBITDA multiples can offer insight into the value of your business based on its profitability. For example, if comparable companies were recently acquired between 5x – 7x EBITDA, this will be one of the reference points we will utilize in determining our opinion of value.
  • Case Study: We’ll also look at recent acquisitions of companies operating in the same segment and size as you. By examining common valuation drivers, financial metrics, and EBITDA multiples, we can draw parallels to your business and refine our opinion of value further.

Financial Analysis

Once we have market and transactional insights, it’s time to perform a detailed analysis of your business’s financial health and growth prospects.

  • Reviewing Financial Health: We analyze key metrics like revenue growth, profit margins, and operating efficiency to assess how well your business is and has been performing. Consistent (or growing) financials can not only boost your valuation in the market but also demonstrate to buyers that your company is a stable and profitable investment.
  • Impact of Assets and Liabilities: Your business’s assets—such as licenses, medical equipment, inventory, entitled real estate, and proprietary technology— may play a role in determining its value. In certain segments, like behavioral health—substance use disorder clinics, it is vital that out-of-network groups have a standardized marketing system for patient acquisition. Conversely, liabilities like outstanding penalties, reimbursement claw backs, charting/clinical data deficiencies, or restrictive contractual obligations can impact the final valuation.  For example, in hospice it is important to have a program to reduce your cap liability and ensure that all patient charts are completed per the current regulatory standards.
  • Projections and Future Cash Flows: In M&A, it’s not just about your current financials; it’s about where your business is headed. We develop grounded financial projections based on current market conditions, historical performance, and growth potential to demonstrate your company’s future cash flow potential.

Conclusion & Findings

After conducting market research and a thorough analysis of your businesses operational, clinical, and financial performance, we compile our findings to deliver a comprehensive valuation reports.

  • Presenting a Valuation Opinion: We summarize all of the data gathered to provide you with a clear opinion of your business’s value. This valuation is supported by concrete data and expert analysis, ensuring transparency and credibility.
  • Next Steps: Once you have a solid understanding of your company’s value, you’ll be in a strong position to pursue your M&A goals. Whether you’re looking to sell now or later, knowing your valuation allows you to plan your next moves more strategically.

Understanding the process of valuation a healthcare company in today’s market is essential if you’re considering any type of capital event in the near future. By exploring key market drivers, examining recent transactions, conducting a thorough financial analysis, and delivering a well-supported valuation, you can approach any M&A related event with confidence.

Going through the steps of conducting a formal valuation not only helps you gain a clear picture of your company’s worth but also provides you with the opportunity to reach maximum value when entering the market to sell or raise capital. Having a third-party, data-driven analysis can equip you with the information and knowledge to successfully navigate a sale process. At M&A Healthcare Advisors, our goal is to guide you through every step of the way, so you can focus on what matters most—growing and transitioning your business successfully.